Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008029 |
---|---|
Receipt number | R000009455 |
Scientific Title | A feasibility study of capecitabine and oxaliplatin (XELOX) for patients with stage II/III colon cancer. |
Date of disclosure of the study information | 2012/06/01 |
Last modified on | 2018/03/01 18:14:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/05/26 12:12:54 | ||
2 | Update | 2014/05/26 12:34:42 | Recruitment status |
|
3 | Update | 2014/11/09 14:04:49 | Email |
|
4 | Update | 2016/02/16 11:05:00 | Recruitment status |
|
5 | Update | 2016/06/27 11:27:01 | Name of primary person or sponsor Organization Email1 |
|
6 | Update | 2017/03/09 12:22:04 | Narrative objectives1 |
|
7 | Update | 2018/03/01 18:12:35 | Publication of results |
|
8 | Update | 2018/03/01 18:14:30 | Recruitment status |